February 5, 2019
Via: Mass DeviceCellect Biotechnology (NSDQ:APOP) said it is collaborating with Washington University on a study of its ApoGraft stem cell selection technology for bone marrow transplantations. This will be the first clinical trial in the U.S. using Tel Aviv, Israel-based Cellect’s ApoGraft, […]
April 23, 2024
April 11, 2024
March 28, 2024
April 3, 2024
April 8, 2024
April 8, 2024